SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-092617
Filing Date
2022-08-18
Accepted
2022-08-18 17:17:01
Documents
9
Period of Report
2022-09-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2222963-1_def14a.htm DEF 14A 1148279
2 GRAPHIC lg_mallinckrodtpharma-4c.jpg GRAPHIC 26314
3 GRAPHIC sg_paulmbisaro-bw.jpg GRAPHIC 7885
4 GRAPHIC tm2222963d1-icon_chairmanbw.jpg GRAPHIC 2778
5 GRAPHIC tm2222963d1-icon_memberbw.jpg GRAPHIC 2334
6 GRAPHIC tm2222963d1-icon_chairbw.jpg GRAPHIC 3256
7 GRAPHIC tm2222963d1-px_01mallinbw.jpg GRAPHIC 508636
8 GRAPHIC tm2222963d1-px_02mallinbw.jpg GRAPHIC 607012
9 GRAPHIC sg_marktyndall-bw.jpg GRAPHIC 14486
  Complete submission text file 0001104659-22-092617.txt   2765548
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1230
Type: DEF 14A | Act: 34 | File No.: 001-35803 | Film No.: 221178158
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences